Evidence map›Paper›PMID 16470383›Full record

ArticleMolecular genetics and genomics : MGG2006

Enhanced gene targeting frequency in ku70 and ku80 disruption mutants of Aspergillus sojae and Aspergillus oryzae.

Tadashi Takahashi, Tsutomu Masuda, Yasuji Koyama

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Molecular genetics and genomics : MGG, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed.

  1. Article
  2. Article
  3. Engineering Industrial Strain ofAntibiotics (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. CRISPR/Cas9 improves targeted knock-in efficiency inBiotechnology notes (Amsterdam, Netherlands) · 2024
    Article
  10. Review
  11. Article
  12. CRISPR/Cas9-Based Genome Editing and Its Application inJournal of fungi (Basel, Switzerland) · 2022
    Review
  13. Article
  14. A Homologous Recombination System to Generate Epitope-Tagged Target Genes inInternational journal of molecular sciences · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Updates inJournal of fungi (Basel, Switzerland) · 2021
    Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tadashi TakahashiNoda Institute for Scientific Research, 399 Noda, 278-0037, Noda City, Chiba, Japan. ttakahashi@mail.kikkoman.co.jp
Tsutomu Masuda
Yasuji Koyama

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the koji molds Aspergillus sojae and Aspergillus oryzae, exogenous DNA is integrated in the genome, in most cases irrespective of the sequence homology, suggesting that DNA integration occurs predominantly through a nonhomologous end joining pathway where two ku genes, namely, ku70 and ku80, play a key role. To determine the effect of ku gene disruption on the gene targeting frequency, we constructed ku70-, ku80-, and ku70-ku80-disrupted strains of A. sojae and A. oryzae. The gene targeting frequency of the tannase gene in ku70 and ku80 strains of both Aspergillus species was markedly enhanced as compared with that of the parental strains. The gene targeting frequency of the aflR and ku80 genes was also enhanced in an A. sojae ku70 background. Therefore, the koji mold strains with ku-disrupted genes will be excellent tools as hosts for efficient gene targeting.

Indexed as

Gene FrequencyGenes, FungalGene TargetingAntigens, NuclearAspergillus oryzaeDNA-Binding ProteinsDNA RepairDown-RegulationGene DeletionKu AutoantigenPoint MutationAntigens, NuclearDNA-Binding ProteinsKu Autoantigen

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.